RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $283
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $236 to $283.
RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $236 to $283.